[at Seeking Alpha] - James A. Bianco Thanks, Monique. Good afternoon, everyone. For those of you that maybe new to CTI, we're a biopharmaceutical company with one marketed oncology drug and a promising late-stage pipeline. ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment